Revmacentrum MUDr. Mostera s.r.o.

Brno-Zidenice 11 trials 3 recruiting

11 Registered trials

3 Currently recruiting

Organisation

Revmacentrum MUDr. Mostera s.r.o.

Location

Brno-Zidenice, Czechia

Identifier

ORG-100043481

Address

Mosnova 2476/8, Zidenice, 615 00, Czechia

Departments

#2004 : Revmatologie
#2202: Revmatologie
2107: Revmacentrum
CZ10009: Revmatologie a interna
N/A
NA
Not applicable
Rheumatology

Clinical trials at this site (11)

Search interface

A Phase 3 program evaluating the effect of filgotinib in subjects with active axial spondyloarthritis Recruiting

2022-501354-10-01 axial spondyloarthritis 5 2023-06-21
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-experienced Participants with Active Psoriatic Arthritis Recruiting

2024-517284-23-00 Active Psoriatic Arthritis 5 2025-04-23
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the i… Recruiting

2023-504417-67-00 Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiog 6 2020-12-22
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-naïve Participants with Active Psoriatic Arthritis Ended

2023-509239-19-00 Active Psoriatic Arthritis 5 2025-04-03
A Study of the Efficacy and Safety of Guselkumab in Participants with Active Psoriatic Arthritis Ended

2023-504734-21-00 Psoriatic arthritis (PsA) 5 2021-08-30
Guselkumab versus Placebo for the Treatment of Psoriatic Arthritis Axial Disease in Bio-naive Participants Ended

2023-504716-15-00 Psoriatic Arthritis 6 2021-08-06
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or … Ended

2023-505478-14-00 Psoriatic Arthritis 5 2019-05-09
Study to evaluate the pharmacokinetics, safety and tolerability of Secukinumab in patients with GCA or PMR Ended

2023-507667-19-00 Polymyalgia rheumatica (PMR) 3 2024-06-06
Study of efficacy, safety, and tolerability of LNA043 in patients with symptomatic knee osteoarthritis Ended

2023-509937-37-00 Osteoarthritis 4 2021-07-21
Evaluation of upadacitinib in adult subjects with axial spondyloarthritis Ended

2022-501018-78-00 Axial Spondyloarthritis 5 2020-03-23
Phase 3b/4 Study in Rheumatoid Arthritis Ended

2023-508022-10-00 Rheumatoid Arthritis 6 2019-07-25